POTS and anesthesia: a perioperative guide
Fasting is the biggest modifiable risk, and it is the one thing the standard pathway gets wrong for these patients.
Every clinical claim on this page is cited to its source below. How we source clinical content — including the corrections we have made and why.
Postural orthostatic tachycardia syndrome is defined as a sustained heart rate increase of more than 30 beats per minute within ten minutes of standing, with symptoms of orthostatic intolerance and without associated hypotension, persisting more than three months.1 Most of what makes it difficult perioperatively follows from one thing: these patients tolerate volume depletion badly, and the perioperative pathway is built around fasting.
Key takeaways
- Fasting is the biggest modifiable risk. Prolonged NPO time is poorly tolerated, and reported management centers on adequate preoperative hydration.
- Ask for the first case of the day or a clear-fluid allowance up to two hours — this is the single most useful accommodation.
- Induction positioning matters, and published case management specifically emphasizes careful positioning during induction.
- Emergence is the second danger point. Hemodynamic lability may persist, and extended monitored observation is reasonable.
- Bring the medication list. Midodrine, fludrocortisone, ivabradine, beta blockers and salt loading regimens all change the plan.
- POTS travels with other diagnoses — hypermobile EDS, mast cell activation syndrome, gastroparesis — and each adds its own consideration.
Why the perioperative pathway is hostile to POTS
The mechanism is not exotic. POTS patients maintain cerebral perfusion and blood pressure through compensations that depend on intravascular volume and sympathetic tone. Fasting removes the volume. Anesthesia removes the sympathetic tone. Positioning changes remove the postural compensation. The three arrive together.
| Standard step | Why it is harder here |
|---|---|
| Midnight NPO | These patients are frequently volume-depleted at baseline and depend on high fluid and salt intake. A 12-hour fast is a substantial deficit before anything else happens |
| Induction | Sympatholysis on top of an already-depleted circulation. Careful positioning during induction is specifically emphasized in published case management1 |
| Neuraxial technique | Sympathectomy removes the compensation these patients rely on most |
| Emergence and transfer | Sitting up is the provocation that defines the condition. Sequential position changes with a fresh sympathectomy or residual anesthetic are the hazard |
| Discharge home | Reduced oral intake after nausea, plus the same orthostatic problem, without monitoring |
What good management looks like
The published case literature is small but consistent. In two young women with POTS and hypermobile EDS presenting for general anesthesia, management centered on extensive preoperative evaluation, adequate preoperative hydration, careful positioning during induction, gentle emergence and extubation, and robust communication with postoperative caregivers.1
Before the day
- Establish the baseline. Usual resting and standing heart rate, usual blood pressure, and what the patient’s own warning symptoms are.
- Get the medication list and decide on each item — midodrine, fludrocortisone, ivabradine, beta blockers, pyridostigmine, salt tablets. Which continue on the morning of surgery is a decision to make in advance with the prescriber, not at the pre-op desk.
- Ask about co-diagnoses. Hypermobile EDS, mast cell activation syndrome and gastroparesis co-occur frequently and each changes something — positioning, agent selection, aspiration risk.
- Ask what happened last time. Previous anesthetic records are the highest-yield item in any condition with a thin evidence base.
On the day
- Minimize the fast. First case, and clear fluids to two hours where institutional policy allows.
- Intravenous fluid before induction rather than after hypotension. This is the intervention the case literature emphasizes.1
- Have a vasopressor drawn up before induction, not after the first reading.
- Move the patient deliberately. Position before induction where possible; avoid abrupt head-up changes on emergence.
Afterward
- Extended monitored observation is reasonable — a recent obstetric case report describes exactly this approach in a patient with POTS among other comorbidities.2
- Treat nausea aggressively, because vomiting reproduces the volume problem.
- Restore oral intake early, including salt.
- Sit the patient up in stages before expecting them to stand.
An honest note on the evidence. There is no society guideline for the perioperative management of POTS. What exists is case reports, small series, and reasoning from the physiology — which is why previous anesthetic records and the patient’s own knowledge of their condition carry more weight here than they would elsewhere. Most POTS patients know their triggers precisely. That information is clinical data.
For patients: what to say, and how
Many POTS patients arrive at a pre-op interview expecting not to be believed. The way to make the conversation productive is to give the anesthesia provider things they can act on.
- “I have POTS. My baseline heart rate lying down is X and standing is Y.” A number is harder to dismiss than a label.
- “Prolonged fasting makes me significantly worse. Can I be scheduled first, or have clear fluids until two hours before?” This is a concrete, grantable request.
- “I take midodrine at these times and fludrocortisone daily. What would you like me to do on the morning of surgery?” Asking the question surfaces the decision.
- “I also have hypermobile EDS / MCAS / gastroparesis.” Each of these changes the plan independently.
- “Here are records from my last anesthetic.” The single most useful thing you can bring.
Frequently asked questions
Is anesthesia safe with POTS?
Yes, with planning. Published case management in POTS patients undergoing general anesthesia reports good outcomes with extensive preoperative evaluation, adequate preoperative hydration, careful positioning during induction, gentle emergence, and communication with postoperative caregivers.1 The risks are predictable rather than mysterious, and most of them relate to volume status and positioning.
Why is fasting such a problem with POTS?
Because POTS patients maintain blood pressure and cerebral perfusion through compensations that depend heavily on intravascular volume, and many maintain high fluid and salt intake for exactly that reason. A prolonged fast removes that volume before anesthesia removes the sympathetic tone that was compensating for it. Adequate preoperative hydration is the intervention the case literature emphasizes most.1
Should I take my midodrine or fludrocortisone on the morning of surgery?
That should be decided in advance with the prescriber rather than at the pre-op desk. Bring the full list with doses and timings, and ask the question specifically — including salt tablets and any beta blocker or ivabradine.
Can I have a spinal or epidural with POTS?
It is not contraindicated, but neuraxial sympathectomy removes exactly the compensation these patients depend on, so the hemodynamic plan needs to account for it — adequate volume beforehand and a vasopressor prepared rather than fetched. Discuss it specifically rather than assuming either that it is fine or that it is off the table.
What should I tell my anesthesiologist about POTS?
Your baseline lying and standing heart rate, that prolonged fasting makes you worse and whether you can be scheduled early, your full medication list with timings, any co-occurring diagnoses such as hypermobile EDS, mast cell activation syndrome or gastroparesis, and records from any previous anesthetic.
Is POTS related to Ehlers-Danlos syndrome?
They co-occur frequently. POTS is commonly reported alongside hypermobile EDS, and where both are present each contributes its own perioperative considerations — dysautonomia and volume dependence from POTS, joint and skin fragility and local anesthetic resistance from EDS. The full picture is on the Ehlers-Danlos page.
References
- Laserna A, Nishtar M, Vidovich C, Borovcanin Z. Perioperative management of Ehlers-Danlos type III syndrome associated with postural orthostatic tachycardia in patients undergoing general anesthesia. Cureus. 2021;13(11):e19311. doi:10.7759/cureus.19311. Includes the diagnostic definition and the management elements described above.
- Aljuba YM, Shatalin D, Ronenson A, Grenader A, Ioscovich A. Anesthetic management of a pregnant patient with Ehlers-Danlos syndrome undergoing elective cesarean delivery: a case report. Cureus. 2025;17(8):e89400. doi:10.7759/cureus.89400. Describes extended post-anesthesia observation in a patient with POTS among multiple comorbidities.
- Further reading. Perioperative care in patients with Ehlers-Danlos syndromes. Review covering coexisting dysautonomia, mast cell activation syndrome and gastroparesis, and the intraoperative implications of each.
Disclaimer. Reference information for licensed clinicians and students. Not a medical device, and not a substitute for clinical judgment. There is no society guideline for the perioperative management of POTS; the guidance here derives from case reports and physiologic reasoning. Verify against your institutional protocol.
Conditions like this one, with their perioperative implications, ship inside Helix Anesthesia — a point-of-care reference built by a practicing CRNA, cited and available offline. See how we source clinical content.
Helix Anesthesia is a reference tool for the people looking after you rather than something you need yourself — but the sourcing behind every number in it is public, and you are welcome to read it.
How we source clinical contentHypermobility and dysautonomia
- Ehlers-Danlos syndrome — start here
- Mast cell activation syndrome
Preparing for surgery yourself? What to tell your anesthesia provider — the plain-language version. · All clinical answers